| 言語 |
英語
|
| 著者 |
Inoue Satoshi
Clinical Development Department, R&D Division, Daiichi Sankyo Co., Ltd
Tsuneto Satoru
Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto
Aruga Etsuko
Department of Palliative Medicine, Teikyo University School of Medicine, Tokyo, Japan
Ogata Takeshi
Clinical Development Department, R&D Division, Daiichi Sankyo Co., Ltd
Uemori Mitsutoshi
Biostatistics & Data Management Department, R&D, Daiichi Sankyo Co., Ltd, Tokyo
|
| 主題 | hydromorphone; morphine; cancer pain; opioid switching; conversion ratio; efficacy ratio
|
| 掲載誌名 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
|
| 巻 | 48
|
| 号 | 5
|
| 開始ページ | 442
|
| 終了ページ | 449
|
| ISSN | 0368-2811
|
| ISSN（Online） | 1465-3621
|
| 発行日 | 2018-05
|
| DOI | |
| PubMed ID | |
| 出版者 | OXFORD UNIV PRESS
|
| 資料タイプ |
学術雑誌論文
|
| 部局 |
医学部
|
| 備考 | This work was supported by Daiichi Sankyo Company, which paid for all expenses related to preparation of this report and study implementation.
|
